Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, AUSL/AOU Modena, Modena, Italy.
Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy.
Clin Exp Med. 2023 Aug;23(4):1171-1180. doi: 10.1007/s10238-022-00968-0. Epub 2022 Dec 10.
The trajectory of B cell development goes through subsequent steps governed by complex genetic programs, strictly regulated by multiple transcription factors. Interferon regulatory factor 4 (IRF4) regulates key points from pre-B cell development and receptor editing to germinal center formation, class-switch recombination and plasma cell differentiation. The pleiotropic ability of IRF4 is mediated by its "kinetic control", allowing different IRF4 expression levels to activate distinct genetic programs due to modulation of IRF4 DNA-binding affinity. IRF4 is implicated in B cell malignancies, acting both as tumor suppressor and as tumor oncogene in different types of precursors and mature B cell neoplasia. Here, we summarize the complexity of IRF4 functions related to different DNA-binding affinity, multiple IRF4-specific target DNA motif, and interactions with transcriptional partners. Moreover, we describe the unique role of IRF4 in acute leukemias and B cell mature neoplasia, focusing on pathogenetic implications and possible therapeutic strategies in multiple myeloma and chronic lymphocytic leukemia.
B 细胞发育的轨迹经历了后续步骤,这些步骤受复杂的遗传程序控制,由多个转录因子严格调控。干扰素调节因子 4(IRF4)调节从前 B 细胞发育和受体编辑到生发中心形成、类别转换重组和浆细胞分化的关键点。IRF4 的多效性能力是通过其“动力学控制”介导的,由于调节 IRF4 DNA 结合亲和力,不同的 IRF4 表达水平可以激活不同的遗传程序。IRF4 与 B 细胞恶性肿瘤有关,在不同类型的前体细胞和成熟 B 细胞肿瘤中,它既是肿瘤抑制因子,也是肿瘤癌基因。在这里,我们总结了与不同 DNA 结合亲和力、多个 IRF4 特异性靶 DNA 基序以及与转录伙伴相互作用相关的 IRF4 功能的复杂性。此外,我们描述了 IRF4 在急性白血病和 B 细胞成熟肿瘤中的独特作用,重点介绍了多发性骨髓瘤和慢性淋巴细胞白血病中的发病机制意义和可能的治疗策略。